BIOMAT Database Logo BIOMAT Database Logo

Pharmacokinetic and pharmacodynamic studies with long-acting propranolol. 1978

J McAinsh, and N S Baber, and R Smith, and J Young

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D011433 Propranolol A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs. Dexpropranolol,AY-20694,Anaprilin,Anapriline,Avlocardyl,Betadren,Dociton,Inderal,Obsidan,Obzidan,Propanolol,Propranolol Hydrochloride,Rexigen,AY 20694,AY20694,Hydrochloride, Propranolol
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D005082 Physical Exertion Expenditure of energy during PHYSICAL ACTIVITY. Intensity of exertion may be measured by rate of OXYGEN CONSUMPTION; HEAT produced, or HEART RATE. Perceived exertion, a psychological measure of exertion, is included. Physical Effort,Effort, Physical,Efforts, Physical,Exertion, Physical,Exertions, Physical,Physical Efforts,Physical Exertions
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006339 Heart Rate The number of times the HEART VENTRICLES contract per unit of time, usually per minute. Cardiac Rate,Chronotropism, Cardiac,Heart Rate Control,Heartbeat,Pulse Rate,Cardiac Chronotropy,Cardiac Chronotropism,Cardiac Rates,Chronotropy, Cardiac,Control, Heart Rate,Heart Rates,Heartbeats,Pulse Rates,Rate Control, Heart,Rate, Cardiac,Rate, Heart,Rate, Pulse
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

J McAinsh, and N S Baber, and R Smith, and J Young
Studies with long acting propranolol.
January 1984, Postgraduate medical journal,
J McAinsh, and N S Baber, and R Smith, and J Young
Pharmacokinetic and pharmacodynamic comparison of two doses of long acting propranolol (80 and 160 mg) in healthy subjects.
May 1989, British journal of clinical pharmacology,
J McAinsh, and N S Baber, and R Smith, and J Young
The pharmacokinetic and pharmacodynamic interactions of ramipril with propranolol.
January 1993, European journal of clinical pharmacology,
J McAinsh, and N S Baber, and R Smith, and J Young
Pharmacokinetic and pharmacodynamic interactions between nisoldipine and propranolol.
January 1988, Clinical pharmacology and therapeutics,
J McAinsh, and N S Baber, and R Smith, and J Young
[Comparative pharmacodynamic studies on long-acting sulfamethoxypyridazine-sulfonamide].
October 1960, Polski tygodnik lekarski (Warsaw, Poland : 1960),
J McAinsh, and N S Baber, and R Smith, and J Young
Insulin degludec: a long-acting modern insulin analogue with a predictable pharmacokinetic/pharmacodynamic profile.
June 2013, Drugs of today (Barcelona, Spain : 1998),
J McAinsh, and N S Baber, and R Smith, and J Young
A comparative pharmacokinetic study of conventional propranolol and long acting preparation of propranolol in patients with cirrhosis and normal controls.
October 1987, British journal of clinical pharmacology,
J McAinsh, and N S Baber, and R Smith, and J Young
Pharmacokinetic and pharmacodynamic interactions between nifedipine and propranolol or betaxolol.
March 1986, International journal of clinical pharmacology, therapy, and toxicology,
J McAinsh, and N S Baber, and R Smith, and J Young
Pharmacodynamic and Pharmacokinetic Interactions of Propranolol with Garlic (Allium sativum) in Rats.
January 2011, Evidence-based complementary and alternative medicine : eCAM,
J McAinsh, and N S Baber, and R Smith, and J Young
Pharmacodynamic and pharmacokinetic profile of RBx 343E48F0: a novel, long acting muscarinic receptor antagonist.
May 2011, European journal of pharmacology,
Copied contents to your clipboard!